Glucocorticoid Inflammation Paradox in Human Skeletal Muscle
Status:
Withdrawn
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
In this project, we propose to investigate the metabolic consequences of glucocorticoid
therapy, given orally as a 6 day Medrol Dose pack, on human skeletal muscle as measured by
western blotting and PCR and skeletal muscle mitochondrial capacity as measured by
High-Resolution Respirometry in healthy individuals. Medrol is an FDA approved drug with many
clinical indications.